INS and obesity disorder: Previous research on mice lacking Epac2A (Epac2A KO) has demonstrated a propensity for obesity (40), a diminished first phase of insulin secretion (13), and impaired glucose-stimulated insulin secretion under diet-induced insulin resistance (41).